Intellia Therapeutics Inc NTLA 深 滬
等待開盤 10-07 09:30:00 美东时间
20.58
+0.620
+3.11%
華盛通- 最 高21.49
- 今 開21.06
- 成交量 359.65万股
- 最 低 20.38
- 昨 收 19.96
- 總市值 21.40亿
- 52周最高 21.49
- 市盈率 靜 --
- 換手率 3.46%
- 52周最低 5.90
- 委 比 -11.86%
- 總股本 1.04亿
- 歷史最高 202.73
- 量 比 0.68
- 振 幅 5.56%
- 歷史最低 5.90
- 每 手 1
- 風險率 3.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多JMP Securities Upgrades Intellia Therapeutics to Market Outperform, Announces $33 Price Target
JMP Securities analyst Silvan Tuerkcan upgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Market Outperform and announces $33 price target.
10-06 19:01
Acuity, Lithium Americas, Rezolve AI, AES And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
10-01 21:57
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
<p>Intellia Therapeutics will present three-year follow-up data from its Phase 1 trial of nex-z for treating hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN) at the 5th International ATTR Amyloidosis Meeting on September 25. Nex-z, developed using CRISPR/Cas9 gene editing technology, aims to inactivate the TTR gene to reduce amyloid buildup and treat this rare, progressive, and fatal disease.</p>
09-22 11:30
JMP Securities Reiterates Market Perform on Intellia Therapeuticsto Market Perform
JMP Securities analyst Silvan Tuerkcan reiterates Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Market Perform.
09-19 20:40
美股牛股 | 英特尔大涨逾22%，英伟达将向其投资50亿美元；基因编辑公司NTLA涨近30%
英特尔大涨逾22%，英伟达将向其投资50亿美元；基因编辑公司NTLA涨近30%，公司完成遗传疾病治疗研究的受试者招募；中概股房多多涨超20%>>
09-19 16:03
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.
09-19 03:08
Intellia Therapeutics Shares Are Ripping Higher: Here's Why
Intellia Therapeutics Inc (NASDAQ:NTLA) shares are soaring on Thursday after the company completed enrollment in its crucial Phase 3 HAELO trial and laid out its key development milestones.
09-19 02:33
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points...
09-18 22:19
